Patent application number | Description | Published |
20090170818 | (20S)-23,23-Difluoro-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs - This invention discloses (20S)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs, and specifically (20S)-23,23-difluoro-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol, and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity. | 07-02-2009 |
20090170819 | (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs - This invention discloses (20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs, and specifically (20R)-23,23-difluoro-1 α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol, and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity. | 07-02-2009 |
20100009943 | 2-Methylene-(22E)-25-(1-Methylene-Hexyl)-26,27-Cyclo-22-Dehydro-19-Nor-Vit- amin D Analogs - This invention discloses 2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs, and specifically 2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-1α,24(R)-dihydroxyvitamin D | 01-14-2010 |
20100179344 | 2-Alkylidene-18,19-Dinor-Vitamin D Compounds - 2-alkylidene-18,19-dinor-vitamin D compounds are disclosed as well as pharmaceutical uses for these compounds and methods of synthesizing these compounds. These compounds are characterized by low bone calcium mobilization activity and high intestinal calcium transport activity. This results in novel therapeutic agents for the treatment and prophylaxis of diseases where bone formation is desired, particularly osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus. These compounds also exhibit pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis. These compounds also increase both breaking strength and crushing strength of bones evidencing use in conjunction with bone replacement surgery such as hip and knee replacements. | 07-15-2010 |
20110082121 | 1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses - This invention discloses 1-desoxy-2-methylene-19-nor-vitamin D analogs, and specifically (20S)-25-hydroxy-1-desoxy-2-methylene-19-nor-vitamin D | 04-07-2011 |
20120149669 | 22-Haloacetoxy-Homopregnacalciferol Analogs and Their Uses - This invention discloses 22-haloacetoxy-homopregnacalciferol analogs and specifically 22-bromoacetoxy-homopregnacalciferol and pharmaceutical uses therefor. This compound exhibits relatively little calcemic activity and does not promote cellular differentiation off HL-60 leukemia cells, but rather kills the cells. This cell death activity is found in small cell lung carcinoma also, but not in prostate cancer cells. This compound thus causes specific cell death in the absence of changes in calcium levels and without general toxicity in an animal. Therefore it might serve as a useful therapy for treatment of some forms of cancer, such as leukemia and lung cancer. | 06-14-2012 |
20120157418 | 2-Methylene-19-Nor-Vitamin D Analogs and Their Uses - This invention discloses 2-methylene-19-nor-vitamin D analogs, and specifically (20S)-25-hydroxy-2-methylene-19-nor-vitamin D | 06-21-2012 |
20120283227 | (20S)-24-(p-Toluenesulfonyloxy)-25,26,27-Trinorvitamin D3 Analogs and Their Uses - This invention discloses (20S)-24(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D | 11-08-2012 |
20120309719 | (22E)-2-METHYLENE-26,27-CYCLO-22-DEHYDRO-1ALPHA-HYDROXY-19-NORVITAMIN D3 DERIVATIVES - Cyclopropane-containing vitamin D analogs of formulas I and IV are provided. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions. | 12-06-2012 |
20130005686 | 2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs - This invention discloses 2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs, and specifically 2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-1α-hydroxyvitamin D | 01-03-2013 |
20130090486 | Crystallization of 1alpha-Hydroxy-2-Methylene-18,19-Dinor-Homopregnacalciferol - A method of purifying 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol to obtain 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol in crystalline form using precipitation with hexane from ethyl acetate. A method of preparing 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol crystals acceptable for X-ray experiment using precipitation with hexane from benzene by diffusive exchange of the solvents is also described. | 04-11-2013 |
20140206655 | (22E)-2-METHYLENE-22-DEHYDRO-1ALPHA,24,25-TRIHYDROXY-19-NOR-VITAMIN D3 ANALOGS - Disclosed are (22E)-2-methylene-22-dehydro-1,24,25-trihydroxy-19-nor-vitamin D | 07-24-2014 |
Patent application number | Description | Published |
20080309402 | EXTINCTION OF PLASMA ARCS - A circuit configuration reduces electrical energy stored in a lead inductance formed by a plurality of leads that connect a power supply unit with a load. The circuit configuration includes a switching device in operative connection with at least one of the leads for enabling or interrupting power to the load. The circuit configuration also includes a first electrical nonlinear device arranged in parallel with the switching device; an energy storing device arranged in parallel with the switching device and in series with the first electrical nonlinear device; and a pre-charging circuit in operative connection with the energy storing device for charging the energy storing device to a pre-determined voltage level while power to the load is enabled. | 12-18-2008 |
20090160417 | Current limiting device for plasma power supply - The current (I | 06-25-2009 |
20100213903 | REDUCING STORED ELECTRICAL ENERGY IN A LEAD INDUCTANCE - According to a first aspect of the present invention, reducing electrical energy stored in a load or in one or more leads for connecting a power supply with the load is achieved by plasma process power circuitry including a switch in operative connection with at least one of the leads for enabling/interrupting power to the load; a first electrical nonlinear device; an energy storing device arranged in series with the first electrical nonlinear device; and a pre-charging circuit in operative connection with the energy storing device, the pre-charging circuit configured to charge the energy storing device to a pre-determined energy level while power to the load is enabled. | 08-26-2010 |
20140174909 | Generating a Highly Ionized Plasma in a Plasma Chamber - A method of generating a highly ionized plasma in a plasma chamber. A neutral gas is provided to be ionized in the plasma chamber at pressure below 50 Pa. At least one high energy high power electrical pulse is supplied with power equal or larger than 100 kW and energy equal or larger than 10 J, to at least one magnetron cathode in connection with a target in the plasma chamber. A highly ionized plasma is produced directly from the neutral gas in a plasma volume such that the plasma volume cross section increases during a current rise period. Atoms are sputtered from the target with the highly ionized plasma. At least part of the sputtered atoms are ionized. | 06-26-2014 |
20140320015 | REDUCING STORED ELECTRICAL ENERGY IN A LEAD INDUCTANCE - According to a first aspect of the present invention, reducing electrical energy stored in a load or in one or more leads for connecting a power supply with the load is achieved by plasma process power circuitry including a switch in operative connection with at least one of the leads for enabling/interrupting power to the load; a first electrical nonlinear device; an energy storing device arranged in series with the first electrical nonlinear device; and a pre-charging circuit in operative connection with the energy storing device, the pre-charging circuit configured to charge the energy storing device to a pre-determined energy level while power to the load is enabled. | 10-30-2014 |
20150354052 | HIGH-RATE REACTIVE SPUTTERING OF DIELECTRIC STOICHIOMETRIC FILMS - A method of controlling a reactive sputter deposition process includes selecting a control process parameter for a target material and a reactive gas, the target material included in a target acting as a cathode, the reactive sputter deposition process involving forming a compound from a reaction between the target material and reactive gas species associated with the reactive gas in a vacuum chamber; establishing an operation regime for the reactive sputter deposition process for a given target power; and performing, based on the selected control process parameter and the established operation regime, the reactive sputter deposition process in a transition region between a metallic mode and a covered mode through a controlled pulsed reactive gas flow rate into the vacuum chamber, such that a stabilized reactive deposition of the compound on a substrate is achieved, the deposited compound on the substrate comprising a dielectric stoichiometric film. | 12-10-2015 |
Patent application number | Description | Published |
20090206735 | BIPHENYL-METAL COMPLEXES-MONOMERIC AND OLIGOMERIC TRIPLET EMITTERS FOR OLED APPLICATIONS - The present invention relates to light-emitting devices and novel emitter materials as well as emitter systems and, in particular, organic light-emitting devices (OLEDs). In particular, the invention relates to the use of luminescent complexes as emitters in such devices. | 08-20-2009 |
20100141120 | Oligomers of Isonitrile-Metal Complexes as Triplett Emitters for OLED Applications - The present invention relates to light-emitting devices and in particular organic light-emitting devices (OLEDs). In particular, the invention relates to the use of luminescent isonitrile/metal complexes as oligomer emitters in devices of this type. | 06-10-2010 |
20110012099 | OPTOELECTRONIC COMPONENT COMPRISING NEUTRAL TRANSITION METAL COMPLEXES - The invention relates to the use of compositions as emitters or absorbers in an electronic component, wherein the compositions have a first neutral transition metal complex and a second neutral transition metal complex. According to the invention, the first transition metal complex and the second transition metal complex together form a column structure. The invention further relates to a method for the production of electronic components having such compositions. | 01-20-2011 |
20130020560 | BIPHENYL-METAL COMPLEXES-MONOMERIC AND OLIGOMERIC TRIPLET EMITTERS FOR OLED APPLICATIONS - The present invention relates to light-emitting devices and novel emitter materials as well as emitter systems and, in particular, organic light-emitting devices (OLEDs). In particular, the invention relates to the use of luminescent complexes as emitters in such devices. | 01-24-2013 |
20130066092 | USE OF GOLD COMPLEXES IN OPTOELECTRONIC DEVICES - The invention relates to gold(I) complexes having a planar-trigonal coordination geometry and multivalent ligands for use in an optoelectronic device, in particular in organic light-emitting diodes (OLEDs) and in light-emitting electrochemical cells (LEECs). | 03-14-2013 |
20130299744 | METAL COMPLEXES HAVING ADAPTABLE EMISSION COLORS FOR OPTOELECTRONIC DEVICES - The invention relates to a method for increasing the Stokes shift of an emitting metal complex having a given geometry in the region of the metal center in the electronic ground state, wherein said geometry is changing as a result of an optical excitation or an excitation by a hole-electron recombination, and to a polymeric matrix by means of which it is possible to influence the change in geometry in the excited state. | 11-14-2013 |
Patent application number | Description | Published |
20110155954 | Materials for Organic Electroluminescence Devices - The invention relates to mononuclear, neutral copper (1) complexes having a bidentate ligand that binds via nitrogen, and two phosphane or arsane ligands, to the use thereof for producing electronic components, and to electronic devices comprising said complexes. | 06-30-2011 |
20130025649 | BLUE LIGHT EMITTER WITH SINGLET HARVESTING EFFECT FOR USE IN OLEDS AND OTHER ORGANIC-ELECTRONIC DEVICES - The invention relates to the use of a platinum-dicyano-bisisocyanide complex cluster, having a small ΔE distance, in particular between 500 cm | 01-31-2013 |
20130150581 | COPPER (I) COMPLEXES FOR OPTOELECTRONIC DEVICES - The invention relates to neutral mononuclear copper (I) complexes for emitting light and with a structure according to formula (A) in which: M represents: Cu(I); L∩L represents: a single, negatively charged, bidentate ligand; N∩N represents: a diimine ligand (substituted with R and FG), in particular a substituted 2,2′-bipyridine derivative (bpy) or a substituted 1,10-phenanthroline derivative (phen); R represents: at least one sterically demanding substituent for preventing the planarisation of the complex in the excited state; FG=functional group, and represents: at least one second substituent for increasing solubility in organic solvents. The substituent can also be used for electron transport or alternatively for hole transport, said functional group being bound to the diimine ligands either directly or by means of suitable bridges; and the copper (I) complex: having a ΔE(S | 06-13-2013 |
20160043332 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES - The invention relates to mononuclear neutral copper(I) complexes with a bidentate ligand which is bonded via nitrogen and two phosphine or arsine ligands, to the use thereof for the production of electronic components, and to electronic devices comprising these complexes. | 02-11-2016 |
Patent application number | Description | Published |
20090123976 | Compositions and Method for Storage of Nucleic Acid From Bodily Fluids - An aqueous composition comprising a denaturing agent, a chelator, a buffering agent and a protease for the extraction of nucleic acid from a sample of bodily fluid, such as saliva, such that the extracted nucleic acid is stable for at least fourteen days at room temperature and can be directly utilised in an amplification reaction without further processing. In particular, said composition comprises SDS, Cyclohexanediamine tetraacetate, Tris-HCl and proteinase K. A method and kit for the amplification of DNA directly from a bodily fluid, comprising said composition, is further provided. | 05-14-2009 |
20100273218 | COMPOSITIONS AND METHOD FOR STORAGE OF NUCLEIC ACID FROM BODILY FLUIDS - The present invention provides an aqueous composition comprising SDS, Cyclohexanediamine tetraacetate, Tris-HCl and proteinase K for the extraction of nucleic acid from a sample of bodily fluid, such a saliva, wherein the extracted nucleic acid is stable for at least fourteen days at room temperature The composition permits direct use of the extracted and stored DNA in an amplification reaction without further processing. | 10-28-2010 |
20110014658 | COMPOSITIONS AND METHOD FOR STORAGE OF NUCLEIC ACID FROM BODILY FLUIDS - The present invention provides an aqueous composition and method for extracting nucleic acid from a sample of bodily fluid, such as saliva, such that the nucleic acid within said sample remains stable for at least fourteen days at room temperature. The composition permits direct use of the extracted and stored DNA in an amplification reaction without further processing. | 01-20-2011 |
Patent application number | Description | Published |
20120258087 | ISOTONIC BEVERAGE WITH CHELATES - The subject of the invention is an isotonic beverage with chelates containing carbohydrates, mineral amino acid chelates, L-carnitine, sweeteners, flavouring substances, and a diluent, the essential feature of the beverage being the content of up to 0.1 wt % of mineral components in the form of mineral amino acid chelates, preferably bisglycinates and glycinates, from 0.1 to 50 wt % of isomaltulose, up to 15 wt % of L-carnitine and/or its derivatives, from 5 to 84% of carbohydrates, up to 50 wt % of bioactive substances, up to 50 wt % of flavouring substances, up to 80 wt % of polyalcohols, diluents, tableting aids, stabilizers, antioxidants, dyes, and 0.013-25 wt % of sweeteners, whereby its osmolarity is 275-295 mOsm/kg and pH is 2-5. | 10-11-2012 |
Patent application number | Description | Published |
20140285221 | CELL AND METHOD FOR ELECTRICAL MEASUREMENTS OF HIGHLY REACTIVE POWDER AND LIQUID SAMPLES - The invention refers to a chamber for measurements of electrical properties of reactive powder or liquid samples, allowing the measurement of various electrical parameters to be carried out. The present invention provides the chamber in two variants of embodiment: the multiple use chamber and the single use chamber. The construction of the chamber provides the possibility of carrying out the measurements with the sample placed directly between parallel active surfaces of the electrodes placed coaxially and sliding in a precise manner in to a thin-walled cylinder made of insulating material providing electric insulation. Elements remaining in contact with the sample are made of chemically inert materials. Additionally, a module containing a pair of the electrodes and the cylinder made of insulating material is detachable from the rest of device elements, that enables its loading and hermetic closure in a glovebox filled with inert gas. The device provides the possibility of carrying out the electrochemical measurements as a function of temperature and pressure. The present invention also refers to a method of carrying out measurements of electrical properties of reactive powder or fluid samples, wherein a sample is loaded into a measurement chamber in an inert gas atmosphere, then the gaseous phase is removed from spaces between parallel active surfaces of electrodes and additionally, solid samples are subjected to compression, and then in the system of regulated temperature and/or pressure a measurement of a selected electrical parameter as a function of time and/or temperature and/or pressure is carried out. | 09-25-2014 |
20150155570 | SELECTIVE CATALYST, PARTICULARLY FOR ELECTROREDUCTION OF OXYGEN, AN ELECTROCHEMICAL SYSTEM CONTAINING THEREOF, AN PALLADIUM-INERT GAS ALLOY AND USE THEREOF, AND A CELL, PARTICULARLY A PHOTOVOLTAIC CELL CONTAINING THEREOF - The present invention provides a catalyst comprising a layer of metallic palladium implanted with an inert gas ions, an electrochemical system containing thereof, a palladium-inert gas alloy stable in the normal conditions, use thereof and a fuel cell containing thereof. | 06-04-2015 |
20160082515 | A METHOD OF PREPARING PURE PRECIOUS METAL NANOPARTICLES WITH LARGE FRACTION OF (100) FACETS, NANOPARTICLES OBTAINED BY THIS METHOD AND THEIR USE - The invention provides a method of preparing pure precious metal nanoparticles of controlled sizes and having (100) facets, wherein a precursor substance contained in a reagent solution is subjected to a reduction reaction using a reducing agent contained in the reagent solution to provide nanoparticles, and the reduction reaction is stopped by rapid lowering of the reaction solution temperature. In the process of the invention, the need to use surfactants or other organic particles to stabilize the (100) facets is eliminated. | 03-24-2016 |
Patent application number | Description | Published |
20130027098 | System and Method Providing Bandwidth Adjustment In Integral Path of Phase Locked Loop Circuitry - A system incorporating and method of operating phase locked loop circuitry. In one embodiment, having programmable circuitry for adjustment of loop dynamics, a VCO has a first input terminal for selecting phase and frequency characteristics of an output signal and an output terminal on which the output signal is provided. A detector generates first VCO input signals indicative of phase and frequency differences between the VCO output signal and a reference signal. Circuitry digitizes the first VCO input signals and generates an integral path input signal therefrom. Slow integral path circuitry comprising, a first transistor device and a programmable low pass filter: receives the integral path input signal, and provides a low pass filtered version of the integral path input signal to control conduction through the first transistor device and provide a first adjustment signal for adjustment of the frequency of the VCO output signal. | 01-31-2013 |
20130027099 | System, Method and Emulation Circuitry Useful For Adjusting a Characteristic of A Periodic Signal - Systems, methods and circuitry useful for adjusting a periodic signal such as with a voltage controlled oscillator or a delay line. In one series of embodiments, circuits and methods are provided for controlling current flow through first and second parallel paths where an impedance device in one path emulates the impedance characteristics of a different device in the other path. A phase or frequency characteristic of the periodic signal may be adjusted by alternate switching of current through the two paths. | 01-31-2013 |
20130027100 | System and Method for Adjusting a Characteristic of A Periodic Signal with Use of a Filtered Bias Voltage - Circuits and methods for controlling a VCO output signal. A filtered version of an integral path input signal controls current flow through a proportional path. An exemplary embodiment generates an integral path input signal from a digital to analog converter. First integral path circuitry includes a first transistor device and a low pass filter which provides a filtered version of the integral path input signal to a first transistor device to control conduction through the device, providing a first VCO input signal for frequency adjustment of the output signal. Proportional path switching circuitry between a supply terminal and VCO input terminal includes a second transistor device which receives the first VCO input signals to control conduction between the supply terminal and the first VCO input terminal to provide a second signal for adjustment of the phase of the VCO output signal relative to the reference signal. | 01-31-2013 |
20130027119 | System Incorporating Power Supply Rejection Circuitry and Related Method - A system and method providing power supply rejection. One embodiment provides for power supply rejection in PLL or DLL circuitry. First subcircuitry provides second subcircuitry a supply voltage which is a filtered version of power from an external source. The first subcircuitry includes a first field effect transistor and a first low pass filter coupled to receive a signal from the external power source during operation of the second subcircuitry. The filter is coupled to provide a filtered version of the power source signal to the gate of the first transistor, so that when a first source/drain region of the first transistor is connected to receive power from the external source and the gate of the first transistor receives the filtered version of the power source signal, the second source/drain region of the first transistor provides a first modified version of the power received from the external source. | 01-31-2013 |
Patent application number | Description | Published |
20100172411 | HIGH DYNAMIC RANGE CODECS - A method for encoding high dynamic ränge (HDR) images involves providing a lower dynamic ränge (LDR) image, generating a prediction function for estimating the values for pixels in the HDR image based on the values of corresponding pixels in the LDR image, and obtaining a residual frame based on differences between the pixel values of the HDR image and estimated pixel values. The LDR image, prediction function and residual frame can all be encoded in data from which either the LDR image of HDR image can be recreated. | 07-08-2010 |
20130322532 | HIGH DYNAMIC RANGE CODECS - A method for encoding high dynamic range (HDR) images involves providing a lower dynamic range (LDR) image, generating a prediction function for estimating the values for pixels in the HDR image based on the values of corresponding pixels in the LDR image, and obtaining a residual frame based on differences between the pixel values of the HDR image and estimated pixel values. The LDR image, prediction function and residual frame can all be encoded in data from which either the LDR image of HDR image can be recreated. | 12-05-2013 |
20140086321 | HIGH DYNAMIC RANGE CODECS - A method for encoding high dynamic range (HDR) images involves providing a lower dynamic range (LDR) image, generating a prediction function for estimating the values for pixels in the HDR image based on the values of corresponding pixels in the LDR image, and obtaining a residual frame based on differences between the pixel values of the HDR image and estimated pixel values. The LDR image, prediction function and residual frame can all be encoded in data from which either the LDR image of HDR image can be recreated. | 03-27-2014 |
20150156506 | HIGH DYNAMIC RANGE CODECS - A method for encoding high dynamic range (HDR) images involves providing a lower dynamic range (LDR) image, generating a prediction function for estimating the values for pixels in the HDR image based on the values of corresponding pixels in the LDR image, and obtaining a residual frame based on differences between the pixel values of the HDR image and estimated pixel values. The LDR image, prediction function and residual frame can all be encoded in data from which either the LDR image of HDR image can be recreated. | 06-04-2015 |
Patent application number | Description | Published |
20140140197 | APPARATUS, SYSTEM AND METHOD OF CONTROLLING DATA FLOW OVER A COMMUNICATION NETWORK - Some demonstrative embodiments include apparatuses, systems and/or methods of controlling data flow over a communication network. For example, an apparatus may include a communication unit to communicate between first and second devices a transfer response, the transfer response in response to a transfer request, the transfer response including a transfer pending status indicating data is pending to be received at the second device, the communication unit is to communicate the transfer response regardless of whether a retry indicator of the transfer request represents a first request for transfer or a retried request. | 05-22-2014 |
20140140258 | APPARATUS, SYSTEM AND METHOD OF CONTROLLING DATA FLOW OVER A COMMUNICATION NETWORK - Some demonstrative embodiments include apparatuses, systems and/or methods of controlling data flow over a communication network. For example, an apparatus may include a communication unit to control the transfer of a stream of data from a first device to a second device over a communication link, the stream of data including data to be delivered to a plurality of endpoints. For example, the controlling may include communicating between the first and second devices at least one message including at least one endpoint-specific credit consumption unit (CCU) defined with respect to at least one endpoint of the plurality of endpoints. | 05-22-2014 |
20140143436 | APPARATUS, SYSTEM AND METHOD OF TEARING DOWN A PROTOCOL ADAPTATION LAYER (PAL) SESSION - Some demonstrative embodiments include apparatuses, systems and/or methods of tearing down a Protocol Adaptation Layer (PAL) session. For example, an apparatus may include a first PAL communication unit to control a PAL connection, over a PAL, between a first device and a second device, the first PAL communication unit is to control the PAL connection during a session with a second PAL communication unit over a communication link, wherein the first PAL communication unit is to tear down the session according to a tear down procedure. | 05-22-2014 |
20140341110 | APPARATUS, SYSTEM AND METHOD OF PROTOCOL ADAPTATION LAYER (PAL) COMMUNICATION TO INDICATE TRANSITIONING A DEVICE TO A DEFAULT STATE - Some demonstrative embodiments include apparatuses, systems and/or methods of transitioning a device to a default state. For example, an apparatus may include a first Protocol Adaptation Layer (PAL) communication unit to communicate PAL traffic with a second PAL communication unit over a communication link, the PAL traffic comprising traffic of a PAL connection over a PAL, the PAL is above a layer of the communication link, wherein the first PAL communication unit is to communicate a device reset request and a device reset response with the second PAL communication unit over the communication link, the device reset request indicating transitioning of a peripheral device to a default state, the device reset response in response to the device reset request, the device reset response indicating whether the device reset request is successfully handled. | 11-20-2014 |
20140344463 | APPARATUS, SYSTEM AND METHOD OF SUPPORTING STREAMING OVER A PROTOCOL ADAPTATION LAYER (PAL) - Some demonstrative embodiments include apparatuses, systems and/or methods of supporting streaming over a Protocol Adaptation Layer (PAL). For example, an apparatus may include a first PAL communication unit to communicate PAL traffic with a second PAL communication unit over a communication link, the PAL traffic comprising traffic of a PAL connection, over a PAL, between a first device and a second device, the PAL is above a layer of the communication link, the PAL traffic comprising data to be communicated between the first device and one or more endpoints via the second device, wherein the first PAL communication unit is to communicate an endpoint open stream request and an endpoint open stream response with the second PAL communication unit over the communication link. | 11-20-2014 |
Patent application number | Description | Published |
20130130374 | CELLULAR COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USE - Methods for preparing a variety of cell (e.g., hepatocyte) preparations and preparations so prepared are described. Uses of such preparations are described. In one embodiment, centrifugal elutriation is used to separate hepatocytes with preferred characteristics. Such hepatocyte preparations may be used for cryopreservation, multiple cryopreservations, in vitro assays, plating and other methods for which preparations of hepatocytes are useful. | 05-23-2013 |
20140273219 | DIFFERENTIATED CELLULAR COMPOSITIONS AND METHODS FOR THEIR PREPARATION AND USE - The present invention relates to methods for culturing progenitor cells to differentiate primarily into a single population of cells with the same phenotype, and to compositions thereof. In particular, it relates to methods for culturing liver progenitor cells to differentiate primarily into a single population of hepatocyte-like cells, and to compositions thereof. | 09-18-2014 |
20150218513 | HEPATOCYTE PREPARATIONS - Methods for preparing a variety of cell (e.g., hepatocyte) preparations and preparations so prepared are described. Uses of such preparations are described. In one embodiment, centrifugal elutriation is used to separate hepatocytes with preferred characteristics. Such hepatocyte preparations may be used for cryopreservation, multiple cryopreservations, in vitro assays, plating and other methods for which preparations of hepatocytes are useful. | 08-06-2015 |